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Abstract
Background: The prevalence of obesity has increased dramatically worldwide. The obesity epidemic begs for novel
concepts and therapeutic targets that cohesively address ‘‘food-abuse’’ disorders. We demonstrate a molecular link
between impairment of a central kinase (Akt) involved in insulin signaling induced by exposure to a high-fat (HF) diet
and dysregulation of higher order circuitry involved in feeding. Dopamine (DA) rich brain structures, such as striatum,
provide motivation stimuli for feeding. In these central circuitries, DA dysfunction is posited to contribute to obesity
pathogenesis. We identified a mechanistic link between metabolic dysregulation and the maladaptive behaviors that
potentiate weight gain. Insulin, a hormone in the periphery, also acts centrally to regulate both homeostatic and
reward-based HF feeding. It regulates DA homeostasis, in part, by controlling a key element in DA clearance, the DA
transporter (DAT). Upon HF feeding, nigro-striatal neurons rapidly develop insulin signaling deficiencies, causing
increased HF calorie intake.
Methodology/Principal Findings: We show that consumption of fat-rich food impairs striatal activation of the insulin-
activated signaling kinase, Akt. HF-induced Akt impairment, in turn, reduces DAT cell surface expression and function,
thereby decreasing DA homeostasis and amphetamine (AMPH)-induced DA efflux. In addition, HF-mediated dysregulation
of Akt signaling impairs DA-related behaviors such as (AMPH)-induced locomotion and increased caloric intake. We restored
nigro-striatal Akt phosphorylation using recombinant viral vector expression technology. We observed a rescue of DAT
expression in HF fed rats, which was associated with a return of locomotor responses to AMPH and normalization of HF diet-
induced hyperphagia.
Conclusions/Significance: Acquired disruption of brain insulin action may confer risk for and/or underlie ‘‘food-abuse’’
disorders and the recalcitrance of obesity. This molecular model, thus, explains how even short-term exposure to ‘‘the fast
food lifestyle’’ creates a cycle of disordered eating that cements pathological changes in DA signaling leading to weight
gain and obesity.
Citation: Speed N, Saunders C, Davis AR, Owens WA, Matthies HJG, et al. (2011) Impaired Striatal Akt Signaling Disrupts Dopamine Homeostasis and Increases
Feeding. PLoS ONE 6(9): e25169. doi:10.1371/journal.pone.0025169
Editor: Xin-Yun Lu, University of Texas Health Science Center at San Antonio, United States of America
Received May 17, 2011; Accepted August 26, 2011; Published September 28, 2011
Copyright:  2011 Speed et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work is supported by the National Institutes of Health grants DA14684 given to AG and LCD and by the DK085712 grant given to AG and KDN. The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: aurelio.galli@vanderbilt.edu
. These authors contributed equally to this work.
" These authors also contributed equally to this work.
Introduction
Insulin is an essential hormone with pleiotropic effects in
multiple tissues and has an important function in the regulation of
plasma glucose levels in peripheral tissues. In the CNS, insulin
relays homeostatic signals regarding the status of peripheral energy
metabolism. The downstream cellular effects of insulin receptor
signaling include activation of phosphoinositide 3-kinases (PI3K),
which has been demonstrated to play a key role in insulin
regulation of feeding [1] and many other insulin-controlled
processes. PI3K phosphorylates the D-3 position of phosphoino-
sitides to generate PI(3,4,5)P3 (PIP3) [1,2], ultimately activating
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protein kinase B (Akt) at the plasma membrane. Akt is a key
element in insulin and growth factor signaling that controls several
cellular functions, including cell growth and apoptosis [3]. In the
CNS, Akt is involved in feeding behavior [4] as well as in the
regulation of dopamine (DA) signaling [5,6] and DA homeostasis
[7,8,9,10].
The DA transporter (DAT) controls the strength and duration
of DA neurotransmission by mediating synaptic DA clearance via
uptake of DA. DAT is, therefore, a critical regulator of DA
homeostasis. We and others have linked CNS insulin action to DA
homeostasis by demonstrating its ability to regulate DAT
trafficking and function [11,12,13]. Tyrosine kinase inhibitors,
which block the receptors activated by insulin and insulin-like
growth factors, reduce DA clearance by decreasing DAT surface
expression [14]. Inhibition of PI3K and Akt also dramatically
reduces DA clearance and surface expression of DAT [7,15,16].
Thus, evidence indicates that insulin signaling maintains appro-
priate dopaminergic tone by regulating DAT function. Consistent
with this novel role in insulin signaling, insulin receptors (IRs) are
expressed in midbrain DA neurons [17].
DA is an important modulator of complex behaviors, including
motivation to eat and the pleasure derived from feeding [18,19]. A
convincing role for DA in feeding behavior was demonstrated both
by studies revealing profound feeding defects in DA deficient
animals [18,19] and by impaired DA signaling in obesity
[20,21,22]. Functional imaging studies in humans show that upon
eating a palatable meal, DA rich brain regions, such as the
striatum, increase in activity [20]. This increase in activity is
blunted in obesity in a body mass index (BMI)-dependent manner,
an effect accentuated in individuals with a genetic polymorphism
associated with reduced DA D2 receptor (D2R) expression [20].
This suggests that dysregulation of DA neurotransmission occurs
in obese individuals, and that the genetic trait for impaired DA
signaling may predispose to obesity.
In obese rats, DA turnover in the subcortical DA circuitry is
impaired [23], and mRNA expression for DAT, DA receptor, and
tyrosine hydroxylase (TH), all key elements controlling DA
neurotransmission, are reduced [24,25]. Diet-induced obese
(DIO) rats also exhibit impaired electrically stimulated DA release
in slices from both the ventral and dorsal striatum [26], further
supporting the hypothesis that obesity reduces DA neurotrans-
mission in these striatal regions. Consistent with this striatal DA
hypofunction, Johnson and Kenny [22] observed that striatal D2R
were also downregulated in obese rats leading to reward
hypofunction. These data raise the possibility that impaired DA
signaling overrides homeostatic signals that would otherwise
constrain feeding, thereby initiating a cycle of over-eating (or
non-homeostatic consumption), worsening obesity in affected
individuals [12].
Taken together, it is increasingly apparent that DA neurotrans-
mission plays an important role in determining eating patterns.
However, it is unclear how increased caloric intake and/or high-
fat feeding disrupts DA homeostasis, potentially contributing to
obesity and whether restoration of normal DA neurotransmission
normalizes caloric intake. Here, we show that in a well
characterized model of high-fat (HF) feeding [27], impairment of
DA clearance and DA-associated behaviors results from altered
DAT trafficking. The molecular mechanism(s) underlying im-
paired DAT function are striatal insulin resistance and impaired
Akt activity. Restoration of striatal Akt activity with viral genetic
rescue normalizes DAT expression, DA-associated behaviors and
caloric intake. Thus, these data are among the first to provide
evidence linking striatal insulin resistance with striatal DA
hypofunction and obesity.
Results
Diet-induced obesity impairs Akt signaling in striatum
and substantia nigra
Central DA signaling pathways are increasingly recognized in
the regulation of feeding behavior [18,19]. Both animal and
human studies have consistently demonstrated differences in DA
signaling between lean subjects versus those with a spectrum of
eating disorders [18,19,21,26]. These changes localize largely to
the ventral and dorsal striatum [19], implicating non-hypotha-
lamic or ‘‘non-homeostatic’’ dopaminergic mechanisms in path-
ological eating and obesity [26].
We and others have previously demonstrated that insulin
signaling via the downstream kinase, Akt, regulates DA homeo-
stasis in the CNS. Thus, we hypothesized that striatal DA
dysfunction induced by an obesogenic HF diet could arise from
impairment in central insulin signaling (or other tyrosine kinase
signals) through Akt [12]. To test this, we utilized a rat HF feeding
DIO model that is characterized by hypothalamic neuronal insulin
resistance [27,28]. Rats were fed a 60% lard-based, HF diet for 28
days, and controls were fed a micro-nutrient matched 10% low-fat
diet (LF). Throughout the 28 day period, HF rats consumed
significantly more calories than LF animals (Fig. S1A; *p,0.05 by
Student’s t-test), and gained significantly more weight than their
LF counterparts (Fig. S1B; *p,0.05 by Student’s t-test). While
blood glucose levels were not different, plasma insulin levels were
significantly elevated in the HF animals, indicating the presence of
insulin resistance (Fig. S1C, S1D; *p,0.05 by Student’s t-test).
Our model, thus, parallels other DIO models [27].
Akt is activated by phosphorylation at Thr308 in response to
insulin, which is commonly utilized as a marker of insulin action.
To determine whether DIO results in impaired striatal and/or
nigral Akt function, we quantified phosphorylation of Akt at
position Thr308 (pAkt) in immunoblots from rapidly dissected
striatal and nigral brain extracts. HF DIO resulted in a significant
reduction of striatal pAkt compared to LF feeding in rats (Fig. 1A;
*p,0.01 by Student’s t-test). Similar results were obtained in the
substantia nigra (Fig. 1B; *p,0.05 by Student’s t-test), whereas
total Akt levels were unchanged by HF DIO (Fig. 1A, 1B). These
data demonstrate that HF feeding for 28 days leads to DIO as well
as reduced nigra-striatal Akt activation.
HF feeding reduces DA clearance in vivo
Evidence in humans and animal models suggests that
dysfunction in striatal DA homeostasis has a pathophysiological
role in obesity [18,19,21,29]. Thus, we determined whether
changes in striatal insulin function due to HF feeding leads to
impaired DA clearance in vivo using high speed chronoampero-
metry (HSCA). A carbon fiber recording electrode was lowered
into the striatum of anesthetized rats and DA pulsed to measure its
clearance time. The kinetic profile of DA clearance after
application of DA (50 pmol) demonstrated dramatically delayed
clearance in HF compared to LF rats (Fig. 2A). There was no
effect on the signal amplitude or on the rise time of the signal
attained for a given amount of exogenously applied DA (Fig. 2A),
which indicates that HF feeding did not change the rate of DA
diffusion through the extracellular matrix. HF feeding significantly
reduced the rate of DA clearance compared to LF animals across
concentrations of pulsed DA (Fig. 2B, by two-way, repeated
measures ANOVA, F1,24 = 6.843; *p,0.05, **p,0.01 by Bonfer-
roni post-hoc analysis). Thus, HF feeding, which decreases striatal
Akt activity, also decreases striatal DAT function in vivo. The
implication is that impaired striatal Akt activation induced by an
Impaired Striatal Akt Signaling and Feeding
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obesogenic diet may dysregulate DA homeostasis by diminishing
DAT function.
HF feeding reduces DAT cell surface expression
DA clearance is affected by the number of transporters at the
cell surface and by their catalytic function. Therefore, the
reduction in DAT activity observed on a HF diet may
mechanistically result from a reduction in DAT surface expression
and/or activity. We next determined whether HF feeding causes a
decrease in striatal DAT cell surface localization utilizing a
biotinylation assay. Striatal slices (300 mm) from HF and LF rats
were biotinylated and assessed for differences in DAT distribution
by immunoblotting. Representative immunoblots of both biotiny-
lated (surface) and total cell fractions from HF and LF rats (Fig. 3A)
reveal that cell surface DAT expression was significantly reduced
(Fig. 3B, *p,0.05 by Student’s t-test). Total levels of DAT
remained unchanged (Fig. 3A) and surface levels of the Na/K
ATPase, a protein found predominantly at the plasma membrane,
were also unchanged. Thus, HF feeding specifically impairs
cellular trafficking of DAT. These data suggest a novel molecular
mechanism in which DIO, by impairing striatal Akt signaling,
alters DA homeostasis (Fig. 2), namely DAT trafficking (Fig. 3).
Pharmacological inhibition of Akt reduces DAT activity
To confirm the mechanistic link between Akt activity and DAT
expression/function, we inhibited Akt pharmacologically in vivo.
We utilized amphetamine (AMPH), a substrate of DAT that
reverses its transport cycle to cause DA efflux and increase
extracellular DA levels. Here, AMPH was utilized to probe DAT
activity in order to relate these findings to other AMPH-associated
behaviors, such as locomotion (see below). HSCA was used to
monitor AMPH-induced DA efflux in striatum while inhibiting
Akt function with an allosteric inhibitor of Akt (I-Akt1/2), which
targets both Akt1 and Akt2 isoforms [30] and reduces DAT
surface expression [16]. The inhibitor, AMPH, and vehicle control
(aCSF) were intrastriatally applied with a calibrated micropipette
positioned adjacent to the recording electrode. AMPH was applied
to obtain a baseline for DA efflux. Then, I-Akt1/2 or aCSF were
pressure-ejected in the striatum. After an additional 45 minutes,
AMPH was again pressure-ejected and recording continued
(Fig. 4A). The release of DA was calculated as a percent of the
AMPH-induced amperometric signal (peak) during baseline
recording (absence of inhibitor). Inhibition of Akt led to a
significant reduction in the ability of AMPH to cause DA efflux
(Fig. 4A, B, *p,0.01 by Student’s t-test). This supports our
Figure 1. DIO induces a decrease in pAkt(Thr308) in the striatum and substantia nigra. Tissue from the striatum (A) and substania nigra (B)
was analyzed by immunoblotting for levels of pAkt (Thr308) and total Akt. Data are expressed as a percent of LF control rats (LF, n = 6; HF, n = 7;
*p,0.05 by Student t-test;). Data are represented as mean 6 S.E.M.
doi:10.1371/journal.pone.0025169.g001
Figure 2. DA clearance rate is reduced in HF DIO rats. (A) Representative oxidation currents produced by intrastriatal application of exogenous
DA, and converted to a micromolar concentration using a calibration factor. (B) DA clearance rates were obtained by pressure ejecting increasing
pmol amounts of DA in the striatum of anesthetized LF- and HF-fed rats. (n = 4/group, two-way, repeated measures ANOVA, F1,24 = 6.843; *p,0.05;
**p,0.01 by Bonferroni post-hoc analysis). Data are expressed as mean 6 S.E.M.
doi:10.1371/journal.pone.0025169.g002
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hypothesis that changes in Akt function induced either pharma-
cologically or by HF-feeding modify striatal DAT function and
DA homeostasis.
HF feeding impairs AMPH-induced locomotion
Locomotion is a DA-associated behavior and AMPH, which
increases locomotion, requires proper subcortical DA homeostasis
[31]. Therefore, to establish whether HF-induced reductions in
striatal Akt function and DAT activity also impair integrated
striatal DA function in vivo, we measured AMPH-induced
locomotion in HF and LF fed animals. Movement was assessed
by the total beam breaks (activity counts) in a 5 min interval and
plotted over time (Fig. 5A). After 60 min of baseline activity,
AMPH (1.78 mg/kg, i.p.) was administered (arrow) and monitor-
ing continued for 30 min. Baseline locomotor activity (0 to
60 min) was unchanged by HF feeding (Fig. 5B). In contrast,
AMPH-induced locomotion was reduced by HF feeding (Fig. 5C,
*p,0.05 by Student’s t-test). To further determine whether HF
feeding decreases AMPH-induced locomotion additionally by
altering DA receptor signaling, locomotion was examined after
administration of apomorphine (2.0 mg/kg, i.p.), a DA receptor
agonist. Unlike AMPH, apomorphine-induced locomotor activity
(total distance traveled) did not significantly differ between LF and
HF rats over a 60 min period (data not shown). These data are
consistent with the idea that the reduction in AMPH-induced
locomotion induced by HF feeding is mediated by a decrease in
DAT plasma membrane expression (Fig. 3), not impaired DA
receptor signaling.
Virally mediated IRS2 expression rescues Akt activity in
the substantia nigra
To further support our hypothesis that HF DIO impairs DAT
function mechanistically by impairing Akt activity, we employed viral
gene delivery technology to increase expression of insulin receptor
substrate 2 (IRS2), a cytosolic protein upstream of Akt whose
activation increases Akt function [32]. A recombinant herpes simplex
virus (HSV) encoding IRS2 (HSV-IRS2) or an HSV encoding GFP
only (HSV-GFP) as a control were injected into the substantia nigra
of both HF and LF animals. This virus has been previously
demonstrated to generate efficient gene expression in dopaminergic
regions of the rodent brain [33]. We confirmed accurate injection
coordinates and efficient viral neuronal transduction by examining
GFP expression in the cell bodies of the nigral dopaminergic neurons
and in their terminal projections to the striatum (Fig. 6A). Sections
were also immunostained against DAT to mark dopaminergic
neurons. We observed strong co-localization of GFP with DAT in
nigral cell bodies and in striatal terminals (Fig. 6A). Since IRS2 is
upstream of Akt, we anticipated that overexpression of IRS2 would
restore Akt activation in HF animals, as has been observed in other
models [32,33]. A significant increase in IRS2 protein level was
observed in the substantia nigra of HF HSV-IRS2 injected animals
Figure 3. DAT cell surface expression is reduced in the striatum of HF DIO rats. (A) Representative immunoblots of biotinylated (surface)
and total DAT proteins from LF and HF rats. The Na/K ATPase was used as a plasma membrane/loading control. (B) Quantification of DAT
immunoreactivity. DAT surface levels were normalized to the total amount of DAT and expressed as a percent of LF control. (LF, n = 4; HF, n = 5;
**p,0.01 by Students t-test,). Data are represented as mean 6 S.E.M.
doi:10.1371/journal.pone.0025169.g003
Figure 4. Inhibition of Akt reduces DAT-mediated reverse
transport of DA. (A) Representative recordings of striatal extracellular
DA release after microinjection of AMPH (400 mM/125 nl) as measured
by HSCA. Traces were obtained 45 minutes after microinjection of the
inhibitor I-Akt1/2 (1 mM/125 nl, grey trace) or vehicle control (black
trace). (B) Quantification of the peak DA release after microinjection of
AMPH. (control, n = 9; I-Akt1/2, n = 7; t14 = 3.49, *p,0.01, Student’s t-
test. ). Data are represented as mean 6 S.E.M.
doi:10.1371/journal.pone.0025169.g004
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compared to GFP controls (HF GFP) (Fig. 6B, *p,0.05; one-way
ANOVA followed by Bonferroni post hoc test). Importantly, IRS2
overexpression rescued the impairment in basal Akt phosphorylation
observed in HF-fed rats (Fig. 6C; compare HF GFP with HF IRS2,
*p,0.05, one-way ANOVA followed by Bonferroni post hoc test).
These data demonstrate that nigral IRS2 overexpression restores Akt
function in HF DIO animals.
Nigral IRS2 injection rescues DAT cell surface expression
in striatum and DA associated behaviors
To mechanistically test whether DIO-induced brain Akt
impairment contributes to DA dysfunction, we next investigated
whether genetic IRS2 rescue restores DAT function and
associated behaviors. In a similar design, LF and HF animals
were injected in the substantia nigra with either HSV-GFP or
HSV-IRS2 and DAT membrane expression quantified in striatal
slices by biotinylation (Fig. 7A, inset). Whereas nigral injection of
HSV-IRS2 did not increase striatal DAT cell surface expression in
LF animals (compared to GFP injected controls), viral IRS2
overexpression in HF animals clearly rescued DAT plasma
membrane expression to the level detected in LF controls
(Fig. 7A; HF IRS2 vs. HF GFP, *p,0.05 by one-way ANOVA,
followed by Bonferroni post hoc test). Thus, genetically rescuing
impaired brain Akt signaling (IRS2) normalized DAT surface
expression. Next, we determined whether this rescue could reverse
the impaired AMPH-induced locomotion observed in HF animals.
Three days after injection with either HSV-GFP or HSV-IRS2
into the substantia nigra of LF and HF rats, locomotion responses
were measured after injection of 1.78 mg/kg (i.p.) of AMPH
(Fig. 7B). HF HSV-GFP injected rats showed reduced cumulative
locomotion 30 minutes after the AMPH injection compared to LF
HSV-GFP injected rats (Fig. 7C, *p,0.05 by one-way ANOVA
followed by Bonferroni post hoc test). HSV-IRS2 injection,
however, rescued this locomotor defect, increasing cumulative
activity to a level that was not significantly different from LF rats
injected with HSV-GFP (Fig. 7C). Thus, we observed that IRS2
rescue of Akt activity restores deficits in both cell surface
expression of DAT and DA-associated behavior in HF rats.
Nigral IRS2 injection restores caloric intake to the levels
of LF fed animals
Studies in both animals and humans, including our own data,
support the concept that HF DIO leads to significant effects on
brain monoamine homeostasis and that this may contribute to
hyperphagia and weight gain [12]. Our data suggest that neuronal
Akt impairment is one mechanism underlying brain DA
dysfunction. Thus, we sought to determine if normalization of
nigra-striatal Akt function by viral rescue (HSV-IRS2 injection in
substantia nigra) in HF animals rescues the hyperphagia observed
on a HF diet. Using the same design as in Fig. 7, HSV-GFP
injected HF rats consumed significantly more calories over three
days compared to LF HSV-GFP rats (Fig. 8). HSV-IRS2 injection
in HF rats normalized caloric intake to the level of HSV-GFP
injected LF rats (Fig. 8). These data provide a mechanistic
framework for linking brain insulin resistance induced by DIO and
impaired Akt activity to striatal DA dysfunction and increased
caloric intake.
Discussion
The prevalence of obesity and related disorders such as diabetes
has increased worldwide, despite a significant effort to therapeu-
Figure 5. AMPH-induced locomotor activity is reduced in HF DIO rats. Locomotor activity was assessed in HF and LF rats before and after an
i.p. injection of AMPH (1.78 mg/kg). (A) Locomotor activity measured by beam breaks over time. Each data point represents 5 minutes of recording
bins. The arrow indicates administration of AMPH at 60 minutes. (B) Total distance traveled by HF and LF rats measured during the first 60 minutes
(before AMPH; p$0.05 by Student’s t-test, n = 12). (C) Total distance traveled measured in HF and LF rats in a 30 min time period after AMPH injection
(*p,0.05 by Students t-test, n = 12). Data are represented as mean 6 S.E.M.
doi:10.1371/journal.pone.0025169.g005
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tically target homeostatic mechanisms. The failure of these efforts
suggests the existence of additional, non-homeostatic mechanisms
that mediate feeding behavior [18]. At the cellular and molecular
level, ‘‘reward’’ (non-homeostatic) circuits originating in DA-rich
brain structures are increasingly understood to provide motivation
and reward stimuli for feeding [18]. The nigrostriatal DA pathway
is involved in motivation to engage in feeding behaviors [19,34],
highlighting DA signaling as an important mediator of feeding and
therefore, potentially in the development of obesity [29].
In the current environment of fast-food and increasing health
issues related to obesity, understanding the effects of high-fat diets
on DA systems have become the focus of intense research.
Compelling data obtained from rats maintained on a ‘‘cafeteria
style’’ diet including highly palatable, high caloric density foods
such as meats, cheeses, cookies, sweetened condensed milk, etc.,
demonstrates defective central DA release [26]. In obese rats,
striatal D2R are also downregulated, leading to reward hypofunc-
tion [22]. Interestingly, reward hypofunction is thought to underlie
mechanisms of illicit substance-use, suggesting the fascinating
possibility that obesity and drug-addiction share a common
neuronal hedonic etiology. While the precise role of the striatum
in regulating nuanced feeding behavior remains to be elucidated, it
is clear that it is sensitive to acquired DA defects mediated by the
diet. Thus, it is important to develop a more complete
understanding of how pathological feeding dysregulates striatal
DA homeostasis and whether restoration of DA homeostasis
normalizes feeding.
Neuronal insulin signaling is exquisitely sensitive to dietary
macronutrient intake [27] and regulates food intake and reward
[35]. In particular, in vivo evidence suggest a critical role of insulin
signaling in cathecolaminergic neurons to control food intake and
energy homeostasis [36]. We and others have shown the molecular
mechanism by which CNS monoaminergic systems are regulated
via insulin/Akt signaling, including the trafficking of monoamine
transporters [8,9,15,37]. Here, we mechanistically linked HF diet
and development of striatal Akt signaling deficiency with
depressed monoamine neurotransmission and predict that these
defects lead to pathological overeating. This prediction provides
the rationale to pharmacologically rescue monoamine signaling in
the brain of obese individuals to modulate feeding. These
observations, as well as similar findings from others, suggest a
link between brain insulin signaling, Akt activation, and
monoamine-related behaviors including caloric intake and loco-
motion. Disruption of brain insulin action (either genetic or
acquired) may, therefore, confer risk for and/or underlie ‘‘food-
abuse’’ by dysregulation of striatal DA homeostasis.
We demonstrate for the first time that HF feeding quickly leads
to striatal insulin resistance and decreased Akt function (Fig. 1).
HF diet also lead to reduced DA clearance (Fig. 2) and DAT
plasma membrane expression (Fig. 3), and viral restoration of Akt
signaling in dopaminergic substantia nigra-striatal neurons
restored DAT surface expression to LF levels (Fig. 6, 7). In order
to validate the mechanistic link between Akt and DAT expression/
function, we also demonstrated that pharmacologic inhibition of
Figure 6. Viral-mediated expression of IRS2 in HF rats restores pAkt levels. Viral injection was performed as described in Methods. (A)
Dopaminergic neurons from the substantia nigra (top row) and projection terminals in the striatum (bottom row) were probed for GFP and DAT after
injection of HSV-GFP into the substantia nigra. The first column (green) represents GFP, the second column (red) DAT, and the third column
represents the merging of these channels together to demonstrate co-expression in the same cell type (scale bars: 10 mm inset; 50 mm main panels;
representative of n = 6 for LF; n = 8 for HF). (B) Representative immunoblot and quantification of IRS2 levels in the substania nigra after injection of
either HSV-GFP or HSV-IRS2 in LF and HF animals (n = 4 per each group, *p,0.05 by one-way ANOVA, followed by Bonferroni post hoc test). (C)
Representative immunoblot and quantification of pAkt (Thr308) levels in the substania nigra after injection of HSV-GFP or HSV-IRS2 in LF and HF
animals. (LF, n = 3; HF, n = 4; *p,0.05 by one-way ANOVA, followed by Bonferroni post hoc test). All data are represented as mean 6 S.E.M.
doi:10.1371/journal.pone.0025169.g006
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striatal Akt acutely impairs DA efflux (Fig. 4). Thus, our data
support a model of diet-induced striatal DA hypofunction resulting
from acquired impairment in brain Akt signaling that can be
rescued by restoring Akt function in nigra-striatal neurons.
It is clear that a high-fat, high-calorie diet leads to obesity, and
reduced DAT surface expression. Locomotor activity is a highly
DA dependent function. We show that HF feeding results in
diminished AMPH-induced locomotion (Fig. 5). This reduction in
locomotor activity is not due to changes in DA receptor signaling
since the ability of apomorphine (a DA receptor agonist) to
induced locomotion was not significantly different in LF versus HF
animals. Our data suggest that HF diet, by impairing DA function,
may support the development of DIO with multiple mechanisms,
including decreased locomotion in response to stimuli.
Because linking Akt dysfunction to DA hypofunction is
fundamental to our model of pathological eating, we sought to
validate this mechanism by determining if viral rescue of Akt
function could, in turn, rescue DAT expression, function, and DA-
associated behaviors. The two main DA projections originate from
the substantia nigra to the dorsal striatum, and from the ventral
tegmental area to the ventral striatum. We focused on dorsal
striatum since the ventral striatum does not appear to underlie the
primary motivation for feeding [18]: disruption of DA signaling in
the nucleus accumbens does not impair food intake [34]. Injection
of a HSV-IRS2 into the cell bodies in the substantia nigra (Fig. 6)
of HF animals increased both IRS2 content and phosphorylation
of Akt in the cell bodies of DA neurons in the substantia nigra to
levels comparable to that of LF animals injected with either
control or IRS2 virus (Fig. 6). This intervention rescued DAT cell
surface expression, in the dorsal striatum of HF animals to levels
observed in LF controls (Fig. 7). These data support our molecular
model of a link between striatal Akt deficiency and impaired DA
function. This led us to ask if this also rescued DA related
behaviors including AMPH-induced locomotion and increased
food intake. Viral rescue of Akt and DAT expression restored the
locomotor response to AMPH (Fig. 7) and, importantly, reduced
caloric intake of rats fed a HF diet to that equivalent of rats fed a
LF diet (Fig. 8), thereby reinforcing a molecular link between Akt,
DA, locomotion and feeding. As the role of striatal function in
feeding behavior begins to emerge, a higher resolution under-
Figure 7. Viral-mediated expression of IRS2 restores surface expression of DAT and AMPH-induced locomotor activity in HF rats.
(A) Inset: Representative immunoblots of biotinylated (surface) and total DAT obtained from LF and HF rats injected either with HSV-GFP (LF GFP or
HF GFP) or HSV-IRS2 (LF IRS2 or HF IRS2). DAT surface levels were normalized to total and expressed as a percentage of LF, HSV-GFP injected rats
(n = 6 per group; *p,0.05 by one-way ANOVA, followed by Bonferroni post hoc test). (B) Locomotor activity measured by beam breaks over time,
with AMPH (arrow) given at 60 minutes (1.78 mg/kg, i.p.) to HF rats injected either with HSV-IRS2 (HF IRS2) or HSV-GFP (HF GFP), and LF rats injected
with HSV-GFP (LF GFP). (C) Total distance traveled in a 30 min time period after injection of AMPH in HF IRS2, HF GFP and LF GFP injected rats (LF
GFP, n = 13; HF GFP, n = 12; HF IRS2, n = 13; *p,0.05 by one-way ANOVA, followed by Newman-Keuls multiple comparison test). Data are represented
as mean 6 S.E.M.
doi:10.1371/journal.pone.0025169.g007
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standing of alterations in DA systems and Akt signaling by HF
diets promises new insights into obesity pathogenesis that may
yield new therapeutic opportunities.
Methods
Animals
All experiments were conducted in accordance with the
National Institutes of Health Guide for the Care and Use of Laboratory
Animals and the Institutional Animal Care and Use Committee
guidelines of Vanderbilt University and the University of Texas
Health Science Center at San Antonio.
Diet induced obesity (DIO) model
Male Sprague-Dawley rats were ordered from Charles River
(Indianapolis, Indiana) at a body weight range of 275–300 g.
Upon arrival to the vivarium, they were housed individually in a
facility kept on a 12-hour light cycle, and were given standard
rodent chow and water ad libidum. All rats were given a diet
consisting of 10% fat (LF) (Research Diets D12492 and D12450B,
New Brunswick, NJ) for 7 days. After this lead-in period, half of
the rats were switched to an isocaloric, nutrient matched high-fat
(HF) diet of 60% fat for 28 more days; the other half of the rats
were kept on the LF diet for the same amount of time. Both rats
and food were weighed daily. Adiposity was determined by
magnetic resonance spectrometry (Echo Medical Systems, Hous-
ton, TX) as performed earlier [27]. DIO was defined as a 10%
increase in body weight in the HF group compared with the LF
group [27]. Caloric consumption was calculated by converting the
weight of the food consumed to kilocalories using the conversions
for the respective diets: 60% fat was 5.24 kcal/gram, and 10% was
3.85 kcal/gram. All experiments were performed in the morning,
with the exception of HSCS recordings that began in the morning
and ran into the afternoon.
Tissue preparation
Tissue punches from specific brain regions were collected
(dorsal striatum and substantia nigra) and homogenized on ice in
buffer containing 20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM
EDTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM
b-glycerolphosphate, 1 mM Na3VO4, 1 mg/ml leupeptin and
1 mM PMSF, then spun at 13,0006g for 30 minutes at 4uC. The
supernatant was taken, the protein content assessed, and analysis
performed.
Brain slice preparation
Methods are as described by Grueter et al. [38]. Rats were
decapitated, the brains quickly removed and placed in an ice-cold,
low-sodium/high-sucrose dissecting solution (consisting of (in
mM): 210 sucrose, 20 NaCl, 2.5 KCl, 1 MgCl2, 1.2 NaH2PO4,
10 glucose, 26 NaHCO3). Hemisected (300 mm) coronal brain
slices containing the striatum were prepared on a vibratome (Leica
VT1000S). Slices were allowed to recover in a submerged holding
chamber (37uC) containing oxygenated (95% O2, 5% CO2)
artificial cerebrospinal fluid (aCSF) that contained the following (in
mM): 124 NaCl, 4.4 KCl, 2.5 CaCl2, 1.3 MgSO4, 1 NaH2PO4, 10
glucose, and 26 NaHCO3 for a recovery period of 60 min before
beginning experiments. Biotinylation assays were then performed.
Biotinylation assays
Biotinylation of brain slices was done as previously described
[39], with some modifications. Hemisected slices (300 mm) were
made as described above and transferred to multiwell submerged
chambers containing oxygenated aCSF with EZ-LinkTM Sulfo-
NHS-SS-Biotin (Thermo Scientific, Rockford, IL) at 1.0 mg/ml
on ice, and incubated for 45 minutes, then washed twice for
10 min in aCSF, and finally incubated in aCSF containing glycine
(100 mM) for two, 20 min periods. Slices were placed onto dishes
on dry ice, and the frozen striatum then was removed and placed
into eppendorf tubes. The frozen tissue punches were homoge-
nized in ice-cold homogenization buffer (1% Triton X-100, 2 mM
sodium orthovanadate, 2 mM sodium fluoride, 25 mM HEPES,
150 mM NaCl, 10 mg/ml aprotinin, and 10 mg/ml leupeptin, and
100 mM phenylmethylsulfonyl fluoride) and then at centrifuged at
17,000 g at 4uC for 30 min. The supernatant was then added to
500 mL of 0.1% Triton X-100 buffer: 150 mM NaCl, 25 mM
HEPES, 2 mM sodium orthovanadate, 2 mM sodium fluoride,
1 mg/ml leupeptin, 1 mg/ml aprotinin, 1 mg/ml pepstatin,
0.5 mM phenylmethylsulfonyl fluoride. The protein concentration
of each sample was measured and equal amounts of protein for
each sample were incubated with ImmunoPure immobilized
streptavidin beads (Pierce) overnight at 4uC under gentle rotation.
Beads were washed three times with 0.1% Triton buffer and
biotinylated proteins were eluted in 50 mL of 26Laemmli sample
loading buffer at 95uC for 5 min, then cooled to room
temperature. Biotinylated and total lysate samples were analyzed
by SDS-PAGE and Western blotted with a DAT primary mouse
monoclonal antibody (Dr. Roxanne Vaughan, UND) and Na/K
ATPase antibody.
Immunoblotting
For Western blotting, determination of immunoreactivity was
conducted according to previously described methods [7,9].
Briefly, tissue samples were separated by SDS-PAGE, and resolved
proteins were transferred to polyvinylidene difluoride (PVDF)
membranes (BioRad), which were incubated for 1 hr in blocking
buffer (5% BSA and 0.1% Tween20 in Tris-buffered saline). The
blots were then incubated with primary antibody overnight at 4uC.
The primary antibodies used included: Akt (1:1000; Cell Signaling
Technology; Danvers, MA), phospho-Akt (Thr308) (1:1000; Cell
Signaling Technology; Danvers, MA) Na/K ATPase (1:450; Dr.
Fambrough, Johns Hopkins University; Baltimore, MD), IRS2
(1:1000; Upstate Technologies; Billerica, MA), and DAT (mouse
Figure 8. HF feeding results in more calories consumed, an
effect reversed by viral injection of IRS2. Caloric consumption of
rats used in experiments in Fig. 7 was calculated over the three day,
post-injection period. (LF GFP, n = 11; HF GFP, n = 18; HF IRS2, n = 13;
**p,0.01; *p,0.05 by one-way ANOVA, followed by Newman-Keuls
multiple comparison test). Data represented are the mean 6 S.E.M.
doi:10.1371/journal.pone.0025169.g008
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monoclonal, 1:500) [40]. All proteins were detected using HRP
conjugated secondary antibodies (1:5000; Santa Cruz Biotechnol-
ogy, Santa Cruz, CA). After chemiluminescent visualization (ECL-
Plus; Amersham; Piscataway, NJ) on Hyper-film ECL film
(Amersham), protein band densities were quantified (Scion Image;
http://www.scioncorp.com) and normalized to control.
Viral Injections
At day 25 of the diet, rats were anesthetized with isofluroene
inhalation and given 0.5 ml bilateral microinjections of HSV
vectors encoding GFP (as a control), or wild-type IRS-2 as
described in Russo et al. [33] over 5 min into the substantia nigra
(A/P 25.3, M/L +/22.0, D/L 27.8, measured from bregma).
After a 5 minute pause, the needle was slowly withdrawn over a
5 minute period. Biochemical and behavioral assays were
performed as described above, 3 days after surgery.
Immunohistochemistry
For immunohistochemical experiments to confirm viral
injections, rats were perfused with 4% paraformaldehyde in
PBS and the intact brains were removed, postfixed for 24 hours,
put into PBS with 20% sucrose overnight, and then sectioned
and processed according to previously published protocols [33].
Briefly, sections were incubated in blocking buffer (containing
BSA) and then with rabbit antibody to GFP (1:5000; Abcam
Inc.; Cambridge, MA) and DAT (mouse monoclonal antibody
16, 1:1000). After incubation with secondary fluorophores,
immunofluorescence was imaged using a Perkin Elmer Ultra-
View confocal microscope with a Nikon Eclipse 2000-U
microscope equipped with a 606 lens with an N.A. of 1.49.
Confocal microscopy was done as previously described [41].
Image processing was performed using Image J and Adobe
PhotoshopH.
High-speed chronoamperometry (HSCA)
HSCA was conducted using the FAST-12 system (Quanteon;
http://www.quanteon.cc) as previously described with some
modification [9,10]. Recording electrode/micropipette assem-
blies were constructed using a single carbon-fiber (30 mm
diameter; Specialty Materials; http://www.specmaterials.com),
which was sealed inside fused silica tubing (Schott, North
America; http://www.schott.com). The exposed tip of the carbon
fiber (150 mm in length) was coated with 5% Nafion (Aldrich
Chemical Co.; htpp://www.sigmaaldrich.com; 3–4 coats baked
at 200uC for 5 min per coat) to provide a 1000-fold selectivity of
DA over its metabolite dihydroxyphenylacetic acid (DOPAC).
Under these conditions, microelectrodes displayed linear amper-
ometric responses to 0.5–10 mM DA during in vitro calibration in
100 mM phosphate-buffered saline (pH 7.4). Animals were
anesthetized with injections of urethane (850 mg/kg, i.p.) and
a-chloralose (85 mg/kg, i.p.), fitted with an endotracheal tube to
facilitate breathing, and placed into a stereotaxic frame (David
Kopf Instruments; http://www.kopfinstruments.com). To locally
deliver test compounds (see below) close to the recording site, a
glass single or multi-barrel micropipette (FHC; http://www.fh-
co.com) was positioned adjacent to the microelectrode using
sticky wax (Moyco; http://www.moycotech.com). The center-to-
center distance between the microelectrode and the micropipette
ejector was 300 mm. For experiments in Figure 2 the microelec-
trode was filled with DA. The study in Figure 4 used a
multibarrel configuration in which barrels contained AMPH
(400 mM) or vehicle (aCSF) and a third barrel contained the Akt
inhibitor (1 mM). The electrode/micropipette assembly was
lowered into the striatum at the following coordinates (in mm
from bregma, Paxinos, G. and Watson, C. The Rat Brain in
Stereotaxic Coordinates, New York, Academic Press, 1998): A/P
+1.5; M/L, +/22.2; D/V, 23.5 to 25.5. The application of
solutions was accomplished using a Picospritzer II (General Valve
Corporation; http://www.parker.com) in an ejection volume of
1002150 nl (5–25 psi for 0.25–3 s). After ejection of test agents,
there is an estimated 10–200-fold dilution caused by diffusion
through the extracellular matrix. To record the efflux and
clearance of DA at the active electrode, oxidation potentials -
consisting of 100-ms pulses of 550 mV, each separated by a 1-s
interval during which the resting potential was maintained at
0 mV - were applied with respect to an Ag/AgCl reference
electrode implanted into the contralateral superficial cortex.
Oxidation and reduction currents were digitally integrated during
the last 80 ms of each 100 ms voltage pulse. For each recording
session, DA was identified by its reduction/oxidation current
ratio: 0.55–0.80. At the conclusion of each experiment, an
electrolytic lesion was made to mark the placement of the
recording electrode tip. Rats were then decapitated while still
anesthetized, and their brains were removed, frozen on dry ice,
and stored at 280uC until sectioned (20 mm) for histological
verification of electrode location within the striatum. HSCA data
were analyzed with GraphPad PrismH.
Locomotor activity
Locomotor activity was assessed by placing the rat in a
26661623 cm high plexiglass chamber located within sound-
attenuating cubicles. Horizontal activity was measured with four
pairs of infrared photobeams positioned 4 cm above the floor of
the chamber. Each beam was placed 15 cm away from the next
immediate photobeam and the two extreme photobeams were
located 8 cm away from the floor sides. An hour baseline was
recorded, rats were given AMPH (1.78 mg/kg, i.p.) and placed
immediately back into the chambers to continue recording for
60 minutes. The data was collected in 5 minute periods over each
60 minute test.
Supporting Information
Figure S1 HF feeding results in weight gain as well as
increased caloric intake and plasma insulin, but not
changes in plasma glucose. The HF-fed rats showed a (A)
significant increase in total caloric intake (n = 13/group; *p,0.05
by Student’s t-test) and (B) weight gain (n = 13/group; *p,0.05 by
Student’s t-test) over the 28-day feeding period. On day 28, blood
was collected, and plasma glucose and insulin levels were
measured. (C) Plasma glucose levels were not significantly different
between the two groups (p.0.05; n= 13/group), but (D) insulin
levels were (*p,0.05; n= 13/group). All data are represented as
mean 6 S.E.M.
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